BlackRock’s Biostage, Inc. Common Stock BSTG Stock Holding History

BlackRock’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-609,129	Closed	-$188K	–	5101
2017 Q3	$188K	Buy	609,129 +798	+0.1%	+$320	﹤0.01%	4237
2017 Q2	$252K	Sell	608,331 -1,810	-0.3%	-$575	﹤0.01%	4196
2017 Q1	$224K	Buy	+610,141	New	+$334K	﹤0.01%	4192

BlackRock's BSTG Position: Q4 2017 in Review

BlackRock sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 609,129 shares — an estimated $188K sold.

BlackRock first reported a position in BSTG in Q1 2017 and held it in 3 quarters. The position peaked at $252K in Q2 2017. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

BlackRock reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
BlackRock sold 609,129 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $188K.
BlackRock first reported a position in Biostage, Inc. Common Stock in Q1 2017 and held it in 3 quarters.
BlackRock's Biostage, Inc. Common Stock position peaked at $252K in Q2 2017.
0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.